New progress in personalizing treatment of sarcoma using AI
RI-MUHC researcher leads the development of the first multimodal deep learning model to optimize care for individual cancer patients
Sarcomas are rare cancers that develop in the bones and soft tissues, such as fat, muscles, and connective tissues. With over 70 different subtypes of soft tissue sarcoma (STS), each with unique characteristics and survival rates, finding universally effective treatments has been challenging.
SOURCE: RI-MUHC